Angiogenic effects of combined gene therapeutic construction pcDNA_VEGF165/Ang-1 in conditions of modeling chronic limb ischemia in vivo

Authors:

Abstract
The combined plasmid construct pcDNA_VEGF165/Ang-1 has a pronounced angiogenic effect under the conditions of the modeled experimental chronic insufficiency of arterial blood supply to the limb. A single local administration of pcDNA_VEGF165/Ang-1 at a dose of 100 μg into the ischemic skeletal muscle of laboratory animals starting from the 14th day after therapy stimulates the formation of microcirculatory bed vessels with a statistically significant increase in the number of capillaries. The use of the gene therapeutic substance pcDNA_VEGF165/Ang-1 allows for complete restoration of impaired blood supply in the muscles of the thigh and lower leg of the rats by the 28th day of observation, creates conditions for maintaining a long-term positive effect until the end of the experiment (42nd day) while maintaining the number of blood vessels in one muscle fiber not lower than the healthy tissue indicator.

This publication has 8 references indexed in Scilit: